F. Fouhy, R. P. Ross, G. F. Fitzgerald, C. Stanton, and P. D. Cotter, Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps, Gut Microbes, vol.3, issue.3, pp.203-223, 2012.

M. Rastelli, C. Knauf, and P. D. Cani, Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders, Obes Silver Spring Md, vol.26, issue.5, pp.792-800, 2018.

F. H. Karlsson, V. Tremaroli, I. Nookaew, G. Bergström, C. J. Behre et al., Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, vol.498, issue.7452, pp.99-103, 2013.

H. K. Pedersen, V. Gudmundsdottir, H. B. Nielsen, T. Hyotylainen, T. Nielsen et al., Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, vol.535, issue.7612, pp.376-81, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01594855

L. Chatelier, E. Nielsen, T. Qin, J. Prifti, E. Hildebrand et al., Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, issue.7464, pp.541-547, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01190602

A. Cotillard, S. P. Kennedy, L. C. Kong, E. Prifti, N. Pons et al., Dietary intervention impact on gut microbial gene richness, Nature, vol.500, issue.7464, pp.585-593, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01001543

P. J. Turnbaugh, F. Bäckhed, L. Fulton, and J. I. Gordon, Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome, Cell Host Microbe, vol.17, issue.4, pp.213-236, 2008.

T. Yatsunenko, F. E. Rey, M. J. Manary, I. Trehan, M. G. Dominguez-bello et al., Human gut microbiome viewed across age and geography, Nature, vol.486, issue.7402, pp.222-229, 2012.

A. Prifti, E. Belda, E. Ichou, F. Kayser, B. D. Dao et al., Major microbiota dysbiosis in severe obesity: fate after bariatric surgery, Gut, 2018.

*. , This study demonstrate that severe obesity is associated with a dramatic increased prevalence of low MGR. Bariatric surgery is able to partially restore gut microbiota dysbiosis

J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu et al., A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, vol.490, issue.7418, pp.55-60, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01204262

K. H. Allin, V. Tremaroli, C. R. Jensen, B. Damgaard, M. Bahl et al., Aberrant intestinal microbiota in individuals with prediabetes, Diabetologia, vol.61, issue.4, pp.810-830, 2018.

Ö. Aydin, M. Nieuwdorp, and V. Gerdes, The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes, Curr Diab Rep, vol.18, issue.8, p.55, 2018.

J. Debédat, C. Amouyal, A. , J. Clément, and K. , Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome? Semin Immunopathol, 2019.

P. D. Cani, S. Possemiers, T. Van-de-wiele, Y. Guiot, E. A. Rottier et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, issue.8, pp.1091-103, 2009.

E. M. Dewulf, P. D. Cani, S. P. Claus, S. Fuentes, P. Puylaert et al., Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women, Gut, vol.62, issue.8, pp.1112-1133, 2013.

E. E. Canfora, C. M. Van-der-beek, G. Hermes, G. H. Goossens, J. Jocken et al., Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, Obese Prediabetic Individuals, vol.153, pp.87-97, 2017.

H. Koutnikova, B. Genser, M. Monteiro-sepulveda, J. Faurie, S. Rizkalla et al., Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials, BMJ Open, vol.9, issue.3, p.17995, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02165922

A. P. Liou, M. Paziuk, J. Luevano, S. Machineni, P. J. Turnbaugh et al., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity, Sci Transl Med, vol.5, issue.178, pp.178-219, 2013.

V. Tremaroli, F. Karlsson, M. Werling, M. Ståhlman, P. Kovatcheva-datchary et al., Rouxen-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation, Cell Metab, vol.22, issue.2, pp.228-266, 2015.

L. J. Brandt, O. C. Aroniadis, M. Mellow, A. Kanatzar, C. Kelly et al., Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection, Am J Gastroenterol, vol.107, issue.7, pp.1079-87, 2012.

M. J. Hamilton, A. R. Weingarden, M. J. Sadowsky, and A. Khoruts, Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection, Am J Gastroenterol, vol.107, issue.5, pp.761-768, 2012.

C. R. Kelly, L. De-leon, and N. Jasutkar, Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results, J Clin Gastroenterol, vol.46, issue.2, pp.145-154, 2012.

E. Mattila, R. Uusitalo-seppälä, M. Wuorela, L. Lehtola, H. Nurmi et al., Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection, Gastroenterology, vol.142, issue.3, pp.490-496, 2012.

E. Gough, H. Shaikh, and A. R. Manges, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.53, issue.10, pp.994-1002, 2011.

B. Cui, Q. Feng, H. Wang, M. Wang, Z. Peng et al., Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results, J Gastroenterol Hepatol, vol.30, issue.1, pp.51-59, 2015.

E. Van-nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal et al., Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, issue.5, pp.407-422, 2013.

, This RCT is the first to demonstrate the efficacy of FMT to cure clostridium difficile infection

I. Youngster, J. Sauk, C. Pindar, R. G. Wilson, J. L. Kaplan et al., Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.58, issue.11, pp.1515-1537, 2014.

, This study demonstrate for the first time the efficacy of capsulized oral fecal microbiota transfer

G. Cammarota, L. Masucci, G. Ianiro, S. Bibbò, G. Dinoi et al., Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Aliment Pharmacol Ther, vol.41, issue.9, pp.835-878, 2015.

C. H. Lee, T. Steiner, E. O. Petrof, M. Smieja, D. Roscoe et al., Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.315, issue.2, pp.142-151, 2016.

M. N. Quraishi, M. Widlak, N. Bhala, D. Moore, M. Price et al., Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection, Aliment Pharmacol Ther, vol.46, issue.5, pp.479-93, 2017.

C. M. Surawicz, L. J. Brandt, D. G. Binion, A. N. Ananthakrishnan, S. R. Curry et al., Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections, Am J Gastroenterol, vol.108, issue.4, pp.478-98, 2013.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, issue.2, pp.1-26, 1920.

L. C. Mcdonald, D. N. Gerding, S. Johnson, J. S. Bakken, K. C. Carroll et al., Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clin Infect Dis Off Publ Infect Dis Soc Am, vol.66, issue.7, pp.987-94, 2018.

J. König, A. Siebenhaar, C. Högenauer, P. Arkkila, M. Nieuwdorp et al., Consensus report: faecal microbiota transfer -clinical applications and procedures, Aliment Pharmacol Ther, vol.45, issue.2, pp.222-261, 2017.

G. Cammarota, G. Ianiro, H. Tilg, M. Rajili?-stojanovi?, P. Kump et al., European consensus conference on faecal microbiota transplantation in clinical practice, Gut, vol.66, issue.4, pp.569-80, 2017.

T. J. Borody, S. Paramsothy, and G. Agrawal, Fecal microbiota transplantation: indications, methods, evidence, and future directions, Curr Gastroenterol Rep, vol.15, issue.8, p.337, 2013.

J. L. Anderson, R. J. Edney, and K. Whelan, Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease, Aliment Pharmacol Ther, vol.36, issue.6, pp.503-519, 2012.

F. Zhang, H. Wang, M. Wang, B. Cui, Z. Fan et al., Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease, World J Gastroenterol, vol.19, issue.41, pp.7213-7219, 2013.

N. G. Rossen, J. K. Macdonald, E. M. De-vries, D. Haens, G. R. De-vos et al., Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review, World J Gastroenterol, vol.21, issue.17, pp.5359-71, 2015.

S. C. Lin, C. D. Alonso, and A. C. Moss, Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature, Transpl Infect Dis Off J Transplant Soc, 2018.

Z. Kassam, C. H. Lee, Y. Yuan, and R. H. Hunt, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol, vol.108, issue.4, pp.500-508, 2013.

Y. H. Van-beurden, P. F. De-groot, E. Van-nood, M. Nieuwdorp, J. J. Keller et al., Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection, United Eur Gastroenterol J, vol.5, issue.6, pp.868-79, 2017.

L. P. Smits, K. Bouter, W. M. De-vos, T. J. Borody, and M. Nieuwdorp, Therapeutic potential of fecal microbiota transplantation, Gastroenterology, vol.145, issue.5, pp.946-53, 2013.

D. Drekonja, J. Reich, S. Gezahegn, N. Greer, A. Shaukat et al., Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review, Ann Intern Med, vol.162, issue.9, pp.630-638, 2015.

C. R. Kelly, S. Kahn, P. Kashyap, L. Laine, D. Rubin et al., Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook, Gastroenterology, vol.149, issue.1, pp.223-260, 2015.

I. Youngster, G. H. Russell, C. Pindar, T. Ziv-baran, J. Sauk et al., Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection, JAMA, vol.312, issue.17, pp.1772-1780, 2014.

L. Bircher, C. Schwab, A. Geirnaert, and C. Lacroix, Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology, Microb Biotechnol, vol.11, issue.1, pp.163-75, 2018.

D. Kao, B. Roach, M. Silva, P. Beck, K. Rioux et al., Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.318, issue.20, pp.1985-93, 201728.

G. Cheminet, N. Kapel, A. Bleibtreu, H. Sadou-yaye, A. Bellanger et al., Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France, J Hosp Infect, 2018.

C. Gérard and H. Vidal, Impact of, Gut Microbiota on Host Glycemic Control. Front Endocrinol, vol.10, p.29, 2019.

P. F. De-groot, M. N. Frissen, N. C. De-clercq, and M. Nieuwdorp, Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes, vol.8, pp.253-67, 201704.

A. Vrieze, E. Van-nood, F. Holleman, J. Salojärvi, R. S. Kootte et al., Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterology, vol.143, issue.4, pp.913-916, 2012.

R. S. Kootte, E. Levin, J. Salojärvi, L. P. Smits, A. V. Hartstra et al., e6. ** This study confirmed the efficacy of FMT to improve insulin sensitivity in a larger group of patients and demonstrated the major variability of response, Cell Metab, vol.26, issue.4, pp.611-619, 2017.

A. Everard, C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc Natl Acad Sci, vol.110, issue.22, pp.9066-71, 2013.

H. Plovier, A. Everard, C. Druart, C. Depommier, M. Van-hul et al., A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, vol.23, issue.1, pp.107-120, 2017.

M. C. Dao, E. A. Aron-wisnewsky, J. Sokolovska, N. Prifti, E. Verger et al., Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, Gut, 2015.

R. Jumpertz, D. S. Le, P. J. Turnbaugh, C. Trinidad, C. Bogardus et al., Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans, Am J Clin Nutr, vol.94, issue.1, pp.58-65, 2011.

F. Bäckhed, H. Ding, T. Wang, L. V. Hooper, G. Y. Koh et al., The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci, vol.101, issue.44, pp.15718-15741, 2004.

V. K. Ridaura, J. J. Faith, F. E. Rey, J. Cheng, A. E. Duncan et al., Gut microbiota from twins discordant for obesity modulate metabolism in mice, Science, vol.341, issue.6150, p.1241214, 2013.

A. Clément and K. , The gut microbiome, diet, and links to cardiometabolic and chronic disorders, Nat Rev Nephrol, 2015.

M. Kulecka, A. Paziewska, N. Zeber-lubecka, F. Ambrozkiewicz, M. Kopczynski et al., Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice, Nutr Metab, vol.13, issue.1, p.57, 2016.

N. C. De-clercq, M. N. Frissen, M. Davids, A. K. Groen, and M. Nieuwdorp, Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa, Psychother Psychosom, vol.88, issue.1, pp.58-60, 2019.

N. Alang and C. R. Kelly, Weight gain after fecal microbiota transplantation. Open Forum Infect Dis, vol.2, p.4, 2015.

S. Angelberger, W. Reinisch, A. Makristathis, C. Lichtenberger, C. Dejaco et al., Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation, Am J Gastroenterol, vol.108, issue.10, pp.1620-1650, 2013.

A. M. Seekatz, J. Aas, C. E. Gessert, T. A. Rubin, D. M. Saman et al., Recovery of the gut microbiome following fecal microbiota transplantation. mBio, vol.5, pp.893-00814, 2014.

M. J. Hamilton, A. R. Weingarden, T. Unno, A. Khoruts, and M. J. Sadowsky, High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria, Gut Microbes, vol.4, issue.2, pp.125-160, 2013.

S. S. Li, A. Zhu, V. Benes, P. I. Costea, R. Hercog et al., Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science, vol.352, pp.586-595, 2016.

P. Moayyedi, M. G. Surette, P. T. Kim, J. Libertucci, M. Wolfe et al., Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial, Gastroenterology, vol.149, issue.1, pp.102-109, 2015.

S. Paramsothy, R. Paramsothy, D. T. Rubin, M. A. Kamm, N. O. Kaakoush et al., Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Metaanalysis, J Crohns Colitis, vol.11, issue.10, pp.1180-99, 2017.

S. Vermeire, M. Joossens, K. Verbeke, J. Wang, K. Machiels et al., Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease, J Crohns Colitis, vol.10, issue.4, pp.387-94, 2016.

N. Shin, J. Lee, H. Lee, M. Kim, T. W. Whon et al., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in dietinduced obese mice, Gut, vol.63, issue.5, pp.727-762, 2014.

H. Lee, Y. Lee, J. Kim, A. J. Lee, S. Kong et al., Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes, pp.1-11, 2017.

K. Forslund, F. Hildebrand, T. Nielsen, G. Falony, L. Chatelier et al., Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, vol.528, issue.7581, pp.262-268, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01535324

H. Wu, E. Esteve, V. Tremaroli, M. T. Khan, R. Caesar et al., Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, Nat Med, vol.23, issue.7, pp.850-858, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01608413

L. A. David, C. F. Maurice, R. N. Carmody, D. B. Gootenberg, J. E. Button et al., Diet rapidly and reproducibly alters the human gut microbiome, Nature, vol.505, issue.7484, pp.559-63, 2014.

G. D. Wu, J. Chen, C. Hoffmann, K. Bittinger, Y. Chen et al., Linking long-term dietary patterns with gut microbial enterotypes, Science, vol.334, issue.6052, pp.105-113, 2011.

L. C. Kong, B. A. Holmes, A. Cotillard, F. Habi-rachedi, R. Brazeilles et al., Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects, PloS One, vol.9, issue.10, p.109434, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01365890

R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, Microbial ecology: human gut microbes associated with obesity, Nature, vol.444, issue.7122, pp.1022-1025, 2006.

A. K. Groen and M. Nieuwdorp, An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases, EMBO Mol Med, vol.9, issue.1, pp.1-3, 2017.

, Effect of Vegan Fecal Microbiota Transplantation on Carnitine-and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in P, PubMed -NCBI, 2019.

L. T. Arbel, E. Hsu, and K. Mcnally, Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review, vol.9, p.1599, 2017.

T. Zhang, J. Xiang, B. Cui, Z. He, P. Li et al., Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease, Oncotarget, vol.8, issue.51, pp.88894-903, 2017.

F. Gundling, S. Roggenbrod, S. Schleifer, M. Sohn, and W. Schepp, Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity, Obes Sci Pract, vol.5, issue.1, pp.68-74, 2019.